FOR a country already struggling against a variety of daunting challenges, the monster of infectious diseases, such as the human immunodeficiency virus (HIV), hepatitis B virus (HBV) and hepatitis C virus (HCV), is not only posing a formidable health challenge to society, but also consuming a major chunk of national economy in... read full story
Photo: FILE - In this March 24, 2016 photo, a nurse for eastern Indiana's Fayette County holds one of the syringes provided to intravenous drug users taking part in the county's state-approved needle exchange program at the county courthouse in Connersville, Ind. The effort is in response to a hepatitis C outbreak among IV drug users. In a report released by the Centers for Disease Control and Prevention on Thursday, May 11, 2017, hepatitis C infections have nearly tripled since 2010 _ an increase mainly due to the heroin epidemic. (AP Photo/Rick Callahan)
![](http://web.archive.org./web/20211102003053im_/https://upload.wikimedia.org/wikipedia/commons/thumb/3/3b/HCV_EM_picture_2.png/120px-HCV_EM_picture_2.png)
Hepatitis C
Hepatitis C is an infectious disease affecting primarily the liver, caused by the hepatitis C virus (HCV). The infection is often asymptomatic, but chronic infection can lead to scarring of the liver and ultimately to cirrhosis, which is generally apparent after many years. In some cases, those with cirrhosis will go on to develop liver failure, liver cancer or life-threatening esophageal and gastric varices.
HCV is spread primarily by blood-to-blood contact associated with intravenous drug use, poorly sterilized medical equipment and transfusions. An estimated 130–170 million people worldwide are infected with hepatitis C. The existence of hepatitis C (originally "non-A non-B hepatitis") was postulated in the 1970s and proven in 1989.Hepatitis C only infects humans and chimpanzees.
The virus persists in the liver in about 85% of those infected. This persistent infection can be treated with medication: a combination of peginterferon and ribavirin is the standard therapy. Overall, 50–80% of people treated are cured. Those who develop cirrhosis or liver cancer may require a liver transplant. Hepatitis C is the leading cause of liver transplantation though the virus usually recurs after transplantation. No vaccine against hepatitis C is available.
read more ...Related News
Dengue, Hep E reported in North Darfur
The Ministry of Health in North Darfur reported on Saturday that cases of dengue fever and hepatitis E have emerged in the state. Doctor Mujtaba El Tijani, Director of the...
Reliefweb 2021-10-11, 14:28Woman with Hepatitis C spits in deputy’s eye during ER ruckus
A Crossville woman whom authorities said was being disruptive at the emergency room in Cumberland Medical Center earlier this month has been arrested and charged with...
![](http://web.archive.org./web/20211102003053im_/https://ecdn7.wn.com/or/assets/assets/avp/img/no-ec.png)
United Therapeutics to Present New Data at CHEST Annual Meeting 2021
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Oct. 11, 2021 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation with a...
PR Newswire 2021-10-11, 11:12NanoViricides Announces COVID-19 Clinical Drug Candidate NV-CoV-2 was Effective Against SARS-CoV-2, Further Demonstrating Its Broad-Spectrum ...
SHELTON, CT / ACCESSWIRE / October 11, 2021 / NanoViricides, Inc. ) is a development stage company that is creating special purpose nanomaterials for antiviral therapy. The...
The Associated Press 2021-10-11, 12:13United Therapeutics to Present New Data at CHEST Annual Meeting 2021 (United Therapeutics Corporation)
) Download the PDF version PDF Format (opens in new window) United Therapeutics to Present New Data at CHEST Annual Meeting 2021 A total of 10 abstracts reinforce United...
Public Technologies 2021-10-11, 11:57Pandemic provided perfect storm for substance use and abuse
The stress of the pandemic, coupled with the increased isolation from others and disruption to daily routines, provided a perfect storm for substance use and abuse. While...
Royal Oak Daily Tribune 2021-10-11, 11:50NanoViricides Announces COVID-19 Clinical Drug Candidate NV-CoV-2 was Effective Against SARS-CoV-2, Further Demonstrating Its Broad-Spectrum Pan-Coronavirus Activity (NanoViricides Inc)
) NanoViricides Announces COVID-19 Clinical Drug Candidate NV-CoV-2 was Effective Against SARS-CoV-2, Further Demonstrating Its Broad-Spectrum Pan-Coronavirus Activity...
Public Technologies 2021-10-11, 14:03